CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Takeda Pharmaceutical Company LTD. v. Watson Laboratories Inc. - Florida

1:09-cv-00917

Overview

Case Number 1:09-cv-00917
Filing Date 2009-12-02
Status Terminated
Termination Date 2011-08-10
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Watson Laboratories Inc. - Florida Operating Company

Represented By

5 Attorneys Listed

Mark D. Schuman

Email: mschuman@carlsoncaspers.com

Samuel T. Lockner

Email: slockner@carlsoncaspers.com

Laura D. Hatcher

DLA Piper LLP

Tel: +1 (302) 468-5638

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Matthew J. Goggin

Email: mgoggin@carlsoncaspers.com

Plaintiff

Takeda Pharmaceuticals North America Inc. Operating Company

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

Morris, Nichols, Arsht & Tunnell, 1201 North Market Street

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Takeda Pharmaceutical Company Ltd. Operating Company

Represented By

3 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell

Tel: +1 (302) 658-9200

Morris, Nichols, Arsht & Tunnell, 1201 North Market Street

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Counter Claimant

Watson Pharma Inc. Operating Company

Represented By

2 Attorneys Listed

Laura D. Hatcher

DLA Piper LLP

Tel: +1 (302) 468-5638

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Watson Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Laura D. Hatcher

DLA Piper LLP

Tel: +1 (302) 468-5638

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): 🇯🇵 Japan 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6034239
Tricyclic compounds, their production and use
Filed: 1997-03-06
Issued: 2000-03-07
Expired (Term Ended) +868d PTA
Expires: 2019-07-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+868 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT filed against Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-663850.) - filed by Takeda Pharmaceutical Company LTD., Takeda Pharmaceuticals North America Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mxw, ) Modified on 12/3/2009 (mxw, ). (Entered: 12/03/2009)

Entry #1 • 2009-12-02
1
Pleading / Complaint

COMPLAINT filed against Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-663850.) - filed by Takeda Pharmaceutical Company LTD., Takeda Pharmaceuticals North America Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mxw, ) Modified on 12/3/2009 (mxw, ). (Entered: 12/03/2009)

Entry #1 • 2009-12-02
2
Pleading / Complaint

COMPLAINT filed against Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-663850.) - filed by Takeda Pharmaceutical Company LTD., Takeda Pharmaceuticals North America Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mxw, ) Modified on 12/3/2009 (mxw, ). (Entered: 12/03/2009)

Entry #1 • 2009-12-02
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mxw, ) (Entered: 12/03/2009)

Entry #2 • 2009-12-02
1

Disclosure Statement pursuant to Rule 7.1 filed by Takeda Pharmaceutical Company LTD., Takeda Pharmaceuticals North America Inc., identifying Corporate Parent Takeda America Holdings, Inc., for Takeda Pharmaceuticals North America Inc. (mxw, ) (Entered: 12/03/2009)

Entry #3 • 2009-12-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc